Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting

MLA

Shimaa Sherif, et al. “Immune-Related 3-LncRNA Signature with Prognostic Connotation in a Multi-Cancer Setting.” Journal of Translational Medicine, vol. 20, no. 1, Sept. 2022, pp. 1–20. EBSCOhost, https://doi.org/10.1186/s12967-022-03654-7.

APA

Shimaa Sherif, Raghvendra Mall, Hossam Almeer, Adviti Naik, Abdulaziz Al Homaid, Remy Thomas, Jessica Roelands, Sathiya Narayanan, Mahmoud Gasim Mohamed, Shahinaz Bedri, Salha Bujassoum Al-Bader, Kulsoom Junejo, Davide Bedognetti, Wouter Hendrickx, & Julie Decock. (2022). Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting. Journal of Translational Medicine, 20(1), 1–20. https://doi.org/10.1186/s12967-022-03654-7

Chicago

Shimaa Sherif, Raghvendra Mall, Hossam Almeer, Adviti Naik, Abdulaziz Al Homaid, Remy Thomas, Jessica Roelands, et al. 2022. “Immune-Related 3-LncRNA Signature with Prognostic Connotation in a Multi-Cancer Setting.” Journal of Translational Medicine 20 (1): 1–20. doi:10.1186/s12967-022-03654-7.